ArticleJournal of cancer research and clinical oncology2005

The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.

Wolfgang J Köstler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.